ValuEngine reduces Surgery Partners to 'sell' — 3 quick notes

ValuEngine lowered its rating on Surgery Partners' shares from a "hold" to a "sell," according to The Ledger Gazette.

Here are three quick notes:

1. Surgery Partners' shares opened Nov. 24 trading at $8.60 per share.

2. The company's P/E ratio totals 57.

3. Surgery Partners' debt-to-equity ratio is 1.56.